7 digital health ‘unicorn’ exits in 2020

With digital health adoption rates skyrocketing from the COVID-19 pandemic, healthcare ‘unicorn’ activity hit record levels in 2020, according to a recent CB Insights report.

Advertisement

The digital health space saw seven ‘unicorn’ companies, or private companies valued at more than $1 billion, exit. The exit activity, which is when the company goes public or is acquired, nearly doubled the four exits in 2019 and two exits in 2018.

Here are the seven digital health unicorns that exited in 2020 as well as their valuations:

  • GoodRx: $12.7 billion
  • Grail: $8 billion
  • Gan & Lee: $3.6 billion
  • Cure Vac: $2.8 billion
  • One Medical: $1.7 billion
  • Hims & Hers $1.6 billion
  • Butterfly: $1.5 billion

More articles on digital transformation:
Online symptom checkers can lead to delayed treatment for serious conditions: study
Apple, Harvard team up on menstrual symptom study
Fast Company’s 10 most innovative health tech companies of 2021

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.